UK industry launches ‘manifesto’ to speed uptake of new medicines

November 2, 2006
Sales and Marketing

Pharmaceutical industry organisation, the ABPI, has launched a new campaign to increase the uptake of new medicines in the UK, …

NHS staff unite in protest against government policies

November 1, 2006

 NHS employees from across England gathered in Westminster to protest against government reforms and cuts to the health service, which …

GSK suffers pipeline setbacks

November 1, 2006
Research and Development

 A series of problems with GlaxoSmithKline's late stage product pipeline has taken the shine off its third quarter figures.The company …

Pharma’s evolving relationship with NICE

November 1, 2006
Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …

Has pharma got the feelgood factor?

October 30, 2006
Business Services HR, recruitment

People are expecting more from their jobs than they ever have before. The concept of a job for life – …

Modified mice could speed safe drug discoveries

October 27, 2006
Research and Development

 CXR Biosciences, based in Scotland, and Artemis Pharmaceuticals in Germany, have been granted licences to sell their genetically modified mice, …

Protest against NHS cuts gathers momentum

October 26, 2006

 Protests against planned cuts to NHS services are taking place around the UK, with anger rising in a number of …

Most PCTs not funding Pfizer’s Macugen

October 26, 2006

 Patients with wet, age-related macular degeneration are being denied access to the first of a new class of treatment for …

Bristol-Myers Squibb suffers at hands of generic Plavix

October 26, 2006
Sales and Marketing

Figures show that the launch of a generic competitor to Plavix in the US dealt a serious blow to Bristol-Myers …

Takeda launches Actos combination in UK

October 26, 2006
Sales and Marketing

 Takeda has expanded its type II diabetes portfolio in the UK with the launch of Competact, a combination of the …

Cerovive failure another blow for AstraZeneca

October 26, 2006
Research and Development, Sales and Marketing AstraZeneca, Cerovive, neuroscience

 A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …

Lilly underlines its position as major biotech company

October 25, 2006
Research and Development

Eli Lilly has opened the first phase of a $560 million expansion to its US biotech research complex.The news comes …

Freedom to Prescribe v The Formulary

October 24, 2006
GP, NHS, doctors, healthcare

The modern concept of a formulary embraces three basic principles: first, it is a limited list of treatments chosen from …

EU recommends first ever therapy for Hunter syndrome

October 24, 2006
Sales and Marketing

Shire has received full EU recommendation for the use of Elaprase for the long-term treatment of patients with Hunter syndrome.Marketing …

Industry calls for global healthcare systems to be benchmarked

October 13, 2006
Sales and Marketing

Fred Hassan, chief executive of Schering-Plough and new head of an international pharma industry organisation, has called for greater transparency …

New schizophrenia treatment promises no weight gain side-effects

October 13, 2006
Sales and Marketing

Solvay and Wyeth have filed a new treatment for schizophrenia with the US regulators, which promises to be free of …

Watchdog urges NHS to ‘raise its game’

October 12, 2006

An NHS watchdog has told managers the health service must raise its game following a national review of performance revealed …

Pfizer buys British vaccine company PowderMed

October 12, 2006
Research and Development Pfizer, Powdermed, vaccines

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …

Alzheimer’s drug ruling ”a terrible decision”

October 11, 2006
Sales and Marketing

Campaigners are stunned at NICE's final decision not to allow Alzheimer's drugs to be prescribed on the NHS in the …

The Gateway to Local Adoption Series

Latest content